Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Open-label trial of immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults ≥ 50 years of age in Mexico.
Tinoco JC, Juergens C, Ruiz Palacios GM, Vazquez-Narvaez J, Enkerlin-Pauwells HL, Sundaraiyer V, Pathirana S, Kalinina E, Gruber WC, Scott DA, Schmoele-Thoma B. Tinoco JC, et al. Among authors: ruiz palacios gm. Clin Vaccine Immunol. 2015 Feb;22(2):185-92. doi: 10.1128/CVI.00711-14. Epub 2014 Dec 10. Clin Vaccine Immunol. 2015. PMID: 25499011 Free PMC article. Clinical Trial.
Immunogenicity and safety of a booster dose of the 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine coadministered with the tetravalent meningococcal serogroups A, C, W-135 and Y tetanus toxoid conjugate vaccine in toddlers: a randomized trial.
Ruiz-Palacios GM, Huang LM, Lin TY, Hernandez L, Guerrero ML, Villalobos AL, Van der Wielen M, Moreira M, Fissette L, Borys D, Miller JM. Ruiz-Palacios GM, et al. Pediatr Infect Dis J. 2013 Jan;32(1):62-71. doi: 10.1097/INF.0b013e3182784143. Pediatr Infect Dis J. 2013. PMID: 23076383 Clinical Trial.
Early loss of measles antibodies after MMR vaccine among HIV-infected adults receiving HAART.
Belaunzarán-Zamudio PF, García-León ML, Wong-Chew RM, Villasís-Keever A, Cuellar-Rodríguez J, Mosqueda-Gómez JL, Muñoz-Trejo T, Escobedo K, Santos JI, Ruiz-Palacios GM, Sierra-Madero JG. Belaunzarán-Zamudio PF, et al. Among authors: ruiz palacios gm. Vaccine. 2009 Nov 23;27(50):7059-64. doi: 10.1016/j.vaccine.2009.09.063. Epub 2009 Sep 30. Vaccine. 2009. PMID: 19799846
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Among authors: ruiz palacios gm. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.
Ruiz-Palacios GM, Guerrero ML, Bautista-Márquez A, Ortega-Gallegos H, Tuz-Dzib F, Reyes-González L, Rosales-Pedraza G, Martínez-López J, Castañón-Acosta E, Cervantes Y, Costa-Clemens S, DeVos B. Ruiz-Palacios GM, et al. Pediatrics. 2007 Aug;120(2):e253-61. doi: 10.1542/peds.2006-2630. Epub 2007 Jul 2. Pediatrics. 2007. PMID: 17606534 Clinical Trial.
Prevalence of pneumococcal disease, serotype distribution, and antimicrobial susceptibility in Mexican children younger than 5 years of age.
Bautista-Márquez A, Richardson V, Ortiz-Orozco O, Luna-Cruz ME, Carnalla-Barajas MN, Echaniz-Avilés G, Bobadilla-del Valle M, Martínez-Medina L, Montalvo-Vázquez AM, de la Re-Montaño N, Anchondo-Martínez I, Tinoco-Favila JC, Martínez-Aguilar G, Yberri-Zárate I, Girón-Hernández JA, Sifuentes-Osornio J, Guerrero ML, Ruiz-Palacios GM. Bautista-Márquez A, et al. Among authors: ruiz palacios gm. Arch Med Res. 2013 Feb;44(2):142-50. doi: 10.1016/j.arcmed.2012.12.005. Epub 2013 Jan 4. Arch Med Res. 2013. PMID: 23291380
What do we know about Q fever in Mexico?
Araujo-Meléndez J, Sifuentes-Osornio J, Bobadilla-Del-valle JM, Aguilar-Cruz A, Torres-Angeles O, Ramírez-González JL, Ponce-de-León A, Ruiz-Palacios GM, Guerrero-Almeida ML. Araujo-Meléndez J, et al. Among authors: ruiz palacios gm. Rev Invest Clin. 2012 Nov-Dec;64(6 Pt 1):541-5. Rev Invest Clin. 2012. PMID: 23513611
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. Among authors: ruiz palacios gm. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
Combine dengue vaccines to optimize effectiveness.
Macias A, Ruiz-Palacios G, Ramos-Castaneda J. Macias A, et al. Vaccine. 2020 Jun 26;38(31):4801-4804. doi: 10.1016/j.vaccine.2020.05.088. Epub 2020 Jun 5. Vaccine. 2020. PMID: 32507334
219 results